Denali Therapeutics Inc. (DNLI) Fell -5.26% or -1.1 To Price $19.91 On Wednesday


Denali Therapeutics Inc. (DNLI) fell -5.26% or -1.1 to $19.91. It is near 529373 shares traded, which is 261.09% compare to the average total volume 202755. The market cap of DNLI is $1.88 billion. The year to date change is -495.38%. The 52 week price range is from $14.72 to $25.79. Price of DNLI have changed 1.40% during last week. It have changed 9.08% over last month, -6.78% over last 3 months, -2.00% over last 6 months and -2.00% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DNLI is 19.39. It is -2.61% below current price. The 52-week High is 25.79. It is 29.53% from the current price. The 52-week Low is 14.72. It is -26.07% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of DNLI is 37.44 on 2018-05-15. Short % to float is 5.94%. There are some statistics of DNLI. It is has market cap $1.88 billion. The share outstanding is 94.44 million. The average volume is 202755. The percent of top 15 Institution holding is 49.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DNLI is -16.80%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DNLI is -14.75%.


Tags:

Share this post